ProSomnus (NASDAQ:OSA) versus Acutus Medical (NASDAQ:AFIB) Head-To-Head Review

Acutus Medical (NASDAQ:AFIB) and ProSomnus (NASDAQ:OSA) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their profitability, institutional ownership, risk, valuation, analyst recommendations, dividends and earnings.

Insider and Institutional Ownership

31.3% of Acutus Medical shares are owned by institutional investors. Comparatively, 7.9% of ProSomnus shares are owned by institutional investors. 3.5% of Acutus Medical shares are owned by insiders. Comparatively, 8.5% of ProSomnus shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Earnings and Valuation

This table compares Acutus Medical and ProSomnus’ top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Acutus Medical	$16.36 million	1.09	-$39.62 million	($1.51)	-0.40
ProSomnus	$19.39 million	0.91	-$7.14 million	N/A	N/A

ProSomnus has higher revenue and earnings than Acutus Medical.

Analyst Recommendations

This is a breakdown of recent ratings and price targets for Acutus Medical and ProSomnus, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Acutus Medical	0	0	0	0	N/A
ProSomnus	0	0	2	0	3.00

ProSomnus has a consensus price target of $10.00, suggesting a potential upside of 809.09%. Given ProSomnus’ higher probable upside, analysts clearly believe ProSomnus is more favorable than Acutus Medical.

Profitability

This table compares Acutus Medical and ProSomnus’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Acutus Medical	-221.30%	-67.47%	-34.44%
ProSomnus	N/A	N/A	-48.65%

Volatility and Risk

Acutus Medical has a beta of 0.88, indicating that its stock price is 12% less volatile than the S&P 500. Comparatively, ProSomnus has a beta of -0.05, indicating that its stock price is 105% less volatile than the S&P 500.

Summary

ProSomnus beats Acutus Medical on 7 of the 11 factors compared between the two stocks.

About Acutus Medical

Acutus Medical, Inc., an arrhythmia management company, designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact force ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. The company was incorporated in 2011 and is headquartered in Carlsbad, California.

About ProSomnus

ProSomnus, Inc. operates as a medical technology company that develops, manufactures, and markets precision intraoral medical devices for treating and managing patients with obstructive sleep apnea. The company sells its products to sleep dentists, sleep physicians, primary care providers, otolarygologists, and other integrated healthcare service providers through a direct sales force. ProSomnus, Inc. is headquartered in Pleasanton, California.